Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltan Herold

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
World Journal of Diabetes|July 30, 2021
Role and function of granin proteins in diabetes mellitusZoltan Herold, Marton Doleschall, Aniko Somogyi
World Journal of Gastrointestinal Oncology|October 7, 2021
Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary systemZoltan Herold, A Marcell Szasz, Magdolna Dank
Endokrynologia Polska|August 4, 2018
Chromogranin A and its role in the pathogenesis of diabetes mellitusZoltan Herold, Marton Doleschall, Annamaria Kovesdi, et al.
Cancers|March 4, 2020
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 DiabetesZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Diabetology & Metabolic Syndrome|July 21, 2020
Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatmentZoltan Herold, Magdolna Herold, Klara Rosta, et al.
World Journal of Diabetes|October 31, 2022
New therapeutic approaches for type 1 diabetes: Disease-modifying therapiesGeza Nagy, Tekla Evelin Szekely, Aniko Somogyi, et al.
Cancers|January 1, 2021
Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse PrognosisZoltan Herold, Magdolna Dank, Magdolna Herold, et al.
Journal of Diabetes Investigation|December 29, 2019
Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritisZoltan Herold, Magdolna Herold, Peter Nagy, et al.
World Journal of Clinical Cases|September 2, 2022
Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancerZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Biomedicines|March 28, 2024
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid TumorsGyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
World Journal of Diabetes|July 30, 2021
Role and function of granin proteins in diabetes mellitusZoltan Herold, Marton Doleschall, Aniko Somogyi
World Journal of Gastrointestinal Oncology|October 7, 2021
Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary systemZoltan Herold, A Marcell Szasz, Magdolna Dank
Endokrynologia Polska|August 4, 2018
Chromogranin A and its role in the pathogenesis of diabetes mellitusZoltan Herold, Marton Doleschall, Annamaria Kovesdi, et al.
Cancers|March 4, 2020
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 DiabetesZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Diabetology & Metabolic Syndrome|July 21, 2020
Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatmentZoltan Herold, Magdolna Herold, Klara Rosta, et al.
World Journal of Diabetes|October 31, 2022
New therapeutic approaches for type 1 diabetes: Disease-modifying therapiesGeza Nagy, Tekla Evelin Szekely, Aniko Somogyi, et al.
Cancers|January 1, 2021
Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse PrognosisZoltan Herold, Magdolna Dank, Magdolna Herold, et al.
Journal of Diabetes Investigation|December 29, 2019
Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritisZoltan Herold, Magdolna Herold, Peter Nagy, et al.
World Journal of Clinical Cases|September 2, 2022
Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancerZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Biomedicines|March 28, 2024
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid TumorsGyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, et al.
Pageof 4